Molecular profiles of inflammatory myopathies.
Greenberg, Sanoudou, Haslett, Kohane, Kunkel, AH Beggs, and Amato. 2002. “Molecular Profiles of Inflammatory Myopathies.”. Neurology 59 (8): 1170-82.
Search
Search results
186 results found
Nemaline myopathy: a clinical study of 143 cases.
Ryan, Schnell, Strickland, Shield, Morgan, Iannaccone, Laing, AH Beggs, and North. 2001. “Nemaline Myopathy: A Clinical Study of 143 Cases.”. Ann Neurol 50 (3): 312-20.
Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filaments.
Sanoudou, and AH Beggs. 2001. “Clinical and Genetic Heterogeneity in Nemaline Myopathy--a Disease of Skeletal Muscle Thin Filaments.”. Trends Mol Med 7 (8): 362-8.
Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy.
Mills, Yang, Weinberger, Vander Woude, AH Beggs, Easteal, and North. 2001. “Differential Expression of the Actin-Binding Proteins, Alpha-Actinin-2 and -3, in Different Species: Implications for the Evolution of Functional Redundancy.”. Hum Mol Genet 10 (13): 1335-46.
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
Schwartz, Priori, Spazzolini, Moss, Vincent, Napolitano, Denjoy, et al. 2001. “Genotype-Phenotype Correlation in the Long-QT Syndrome: Gene-Specific Triggers for Life-Threatening Arrhythmias.”. Circulation 103 (1): 89-95.
Human neuropilin-1 and neuropilin-2 map to 10p12 and 2q34, respectively.
Rossignol, AH Beggs, Pierce, and Klagsbrun. 1999. “Human Neuropilin-1 and Neuropilin-2 Map to 10p12 and 2q34, Respectively.”. Genomics 57 (3): 459-60.
alpha-actinin-2 is a new component of the dystrophin-glycoprotein complex.
Hance, Fu, Watkins, AH Beggs, and Michalak. 1999. “Alpha-Actinin-2 Is a New Component of the Dystrophin-Glycoprotein Complex.”. Arch Biochem Biophys 365 (2): 216-22.
Molecular genetics of long-QT syndrome.
Wattanasirichaigoon, and AH Beggs. 1998. “Molecular Genetics of Long-QT Syndrome.”. Curr Opin Pediatr 10 (6): 628-34.
51st ENMC International Workshop: Nemaline Myopathy. 13-15 June 1997, Naarden, The Netherlands.
Wallgren-Pettersson, AH Beggs, and Laing. 1998. “51st ENMC International Workshop: Nemaline Myopathy. 13-15 June 1997, Naarden, The Netherlands.”. Neuromuscul Disord 8 (1): 53-6.
A severe muscular dystrophy patient with an internally deleted very short (110 kD) dystrophin: presence of the binding site for dystrophin-associated glycoprotein (DAG) may not be enough for physiological function of dystrophin.
Arikawa-Hirasawa, Koga, Tsukahara, Nonaka, Mitsudome, Goto, AH Beggs, and Arahata. 1995. “A Severe Muscular Dystrophy Patient With an Internally Deleted Very Short (110 KD) Dystrophin: Presence of the Binding Site for Dystrophin-Associated Glycoprotein (DAG) May Not Be Enough for Physiological Function of Dystrophin.”. Neuromuscul Disord 5 (5): 429-38.